F/m Emerald Life Sciences Innovation ETF LFSC

Medalist Rating as of | See Emerald Investment Hub

Morningstar’s Analysis LFSC

Will LFSC outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

F/m Emerald Life Sciences Innovation ETF holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LFSC

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 57.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Travere Therapeutics Inc Ordinary Shares

7.87 10M
Healthcare

Spyre Therapeutics Inc

7.19 9M
Healthcare

Cogent Biosciences Inc

7.16 9M
Healthcare

LivaNova PLC

6.91 8M
Healthcare

Guardant Health Inc

5.78 7M
Healthcare

Corcept Therapeutics Inc

5.42 7M
Healthcare

Mirum Pharmaceuticals Inc

4.98 6M
Healthcare

BillionToOne Inc Ordinary Shares - Class A

4.61 6M
Healthcare

Cytokinetics Inc

4.04 5M
Healthcare

United Therapeutics Corp

3.46 4M
Healthcare

Sponsor Center